Approval · Notice of Compliance 4343 · 1996
DIGIBIND: Notice of Compliance 4343
Issued September 12, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4343
- Date
- September 12, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Specific antibody for digoxin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIGIBIND | 02146967 | Cancelled Post Market |
Medicinal ingredients
- DIGOXIN IMMUNE FAB (OVINE) 38 MG per VIAL